SNX15 Antikörper (C-Term)
Kurzübersicht für SNX15 Antikörper (C-Term) (ABIN184966)
Target
Alle SNX15 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Güteklasse
-
-
Bindungsspezifität
- C-Term
-
Verwendungszweck
- SNX15
-
Sequenz
- EEILRLHLSQ LPP
-
Spezifität
- This antibody is expected to recognise both Human isoforms according to NP_037438.2 and NP_680086.2.
-
Kreuzreaktivität
- Human
-
Aufreinigung
- Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
-
Immunogen
- Peptide with sequence C-EEILRLHLSQLPP, from the C Terminus of the protein sequence according to NP_037438.2, NP_680086.2.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
Western Blot: Approx 48 kDa band seen in Human Kidney lysates and in lysates of cell line HEK293 (calculated MW 38.2 kDa according to NP_037438.2). Recommended for use at 0.2-1 μg/mL. Note: A single approx 30-35 kDa band (probably representing the shorter is
Peptide ELISA: antibody detection limit dilution 1:8000.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.5 mg/mL
-
Buffer
- Supplied at 0.5 mg/mL in Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Minimize freezing and thawing.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Aliquot and store at -20°C, with minimal freeze/thawing. A working aliquot may be refrigerated at 4°C for a few weeks and still remain viable.
-
-
-